More recently, in a cohort of older adults (n = 5047) residing in residential care, Marcum et al. found a significantly lower incidence of cognitive impairment among users of Ang II-stimulators compared to users of Ang II-inhibitors over a median 5.4-month follow-up [73]. This evidence concerns the gene AGT and Cognitive impairment.